Join fme at the Pharmaceutical Manufacturing World Summit

Join fme at the Pharmaceutical Manufacturing World Summit

Every year, the Pharmaceutical Manufacturing World Summit in Boston brings together industry leaders, innovators, and manufacturing experts to explore the future of pharmaceutical production. As both attendees and sponsors, the fme team enjoys this unique opportunity to engage in meaningful conversations, exchange insights, and advise on the technology and data management strategies that shape Life Sciences manufacturing today. Many of the key themes that defined last year’s agenda continue to be critical topics within the industry.

Key Themes Shaping Pharmaceutical Manufacturing World Summit

Year after year, one common thread unifies the agenda: Data is the foundation of transformation for business success.

Whether enabling AI, supporting regulatory compliance, or driving operational efficiency, success depends on having trusted, structured, and accessible data across the product lifecycle. Here are some of the recent areas of focus we’ve repeatedly shared with our clients:

ECM Platform ServicesData as a Strategic Asset

One of the most important points of the conference is data is no longer just operational, it’s transformational. Organizations are increasingly relying on high-quality, accessible data to drive decision-making across supply chains, manufacturing performance, and patient safety.

The ability to treat data as a strategic asset rather than a byproduct has finally been recognized as a competitive differentiator, and has been fme’s focus and mission for over 25 years. We help companies maximize the value and power of their data, ensuring it is structured, reusable, and ready to migrate into powerful solutions that unlock its full value across the enterprise.

digital_infrastructure

Navigating Geopolitical Uncertainty

Global manufacturing strategies are being reshaped by shifting regulatory landscapes, trade policies, and geopolitical tensions. From increased pressure to localize production in the U.S. to evolving FDA leadership and AI regulation, companies are operating in an environment of heightened uncertainty and risk.

fme helps guide organizations through the dynamic data management challenges that can affect supply chain resilience, inspection readiness, and compliance strategies.

Infrastructure Investment and Digital Transformation

The scale of investment in modern manufacturing infrastructure is staggering. Leading pharmaceutical companies are building digitally native, highly automated facilities designed for flexibility, speed, and advanced modalities like cell and gene therapies.

Technologies such as digital twins, robotics, IIoT, and integrated MES/QMS platforms are becoming foundational. At the same time, organizations are recognizing that less than 1% of process data is often fully utilized, highlighting a major opportunity for transformation.

To ensure technology investments address both immediate and long-term needs, it is critical to work with a technology partner that understands the technical and business goals of an integrated research, development, and manufacturing pipeline.

Pricing Pressures Driving Efficiency

With rising costs across the industry, manufacturers are under pressure to do more with less. The focus has shifted toward reducing inefficiencies, eliminating rework, and accelerating system consolidation.

This is where digital enablement and automation powered by clean, high-integrity data are playing a critical role in turning compliance into a value-generating function rather than a cost center.

Innovation Accelerating at Scale

From AI-driven quality transformation to novel manufacturing platforms, innovation is rapidly reshaping the industry.

Highlights from last year included:

  • AI-enabled quality systems and predictive manufacturing
  • Expansion into advanced modalities like ADCs and cell therapies
  • End-to-end digital supply chain orchestration
  • Increasing use of GenAI to enhance quality and operational efficiency

Organizations are not just experimenting. They are scaling these innovations to drive measurable business outcomes before their competition.

Join Us at This Year’s Summit

We’re excited to return to the Pharmaceutical Manufacturing World Summit this year as a sponsor and continue the conversation with industry leaders.

If you’ll be attending, we’d love to connect! Contact us and we’ll schedule a time to discuss your current challenges, share our proven strategies and insights, or explore how to accelerate your digital and data initiatives. If you can’t attend and would like a summary of the essential topics and sessions, let us know.

Master Data and Governance in a New Life Sciences Reality

Master Data and Governance in a New Life Sciences Reality

We are excited to share that fme will be joining the 12th Master Data and Data Governance Excellence In Life Sciences Conference, 4-5 June in Zurich, Switzerland. In the Life Sciences industry, data is no longer just an operational asset, it is the foundation for innovation, regulatory compliance, and commercial success. fme’s experts look forward to participating in these discussions to share our experience and strategies to rescue information from disconnected silos and align it with business goals.

Today, data is no longer a by-product of operations. It is a strategic asset that underpins innovation, regulatory compliance, and commercial success.

Across Regulatory, Clinical, Quality domains, organizations are entering a new data reality. Regulatory expectations, such as IDMP, are accelerating the need for structured, standardized, and interoperable data. At the same time, governance is evolving from control to enablement, where data must actively support processes, analytics, and decision-making. In addition, new AI solutions show amazing promise but are only as effective as the data they are built on.

This shift is redefining long-standing concepts. The idea of a single, static source of truth is giving way to dynamic, connected, and context-driven data ecosystems that must work seamlessly across systems and functions.

The Gap Between Ambition and Execution

Many organizations are investing in AI use cases, data governance frameworks, and master data management initiatives. However, execution remains a challenge.

  • Data is often not AI-ready.
  • Quality issues limit trust and reuse.
  • Governance frameworks exist but are not embedded in daily operations.
  • MDM approaches struggle to scale across domains and keep pace with increasing complexity.

This creates a disconnect between strategy and reality. Without trusted and governed data, transformation initiatives slow down, risk increases, and expected value is not fully realized.

How fme Translates Data Strategy into Execution

At fme, we help Life Sciences organizations turn data ambition into execution. Our approach focuses on building trusted data foundations that support transformation across the full lifecycle:

Data readiness and assessment

We help organizations understand their data landscape through system inventory, quality analysis, and risk identification. This creates clarity before transformation begins.

Master data and governance enablement

We support the design and operationalization of governance frameworks, including data ownership, metadata standards, and harmonization across domains. The focus is on making governance actionable in daily work.

Migration and transformation execution

With deep expertise in platforms such as Veeva Vault, Generis CARA, Documentum, and TrackWise, fme delivers controlled and compliant migrations. Our migration-center® technology enables scalable, repeatable, and auditable execution.

Data quality and remediation

We support ongoing data quality improvement, remediation, and post-go-live stabilization to ensure data remains trusted, usable, and aligned with evolving requirements.

A Practical Path Forward

Success in this new data reality requires more than technology. It requires scalable governance, high-quality data, and the ability to operationalize master data across domains.

fme combines domain expertise, proven methodology, and purpose-built technology to help organizations reduce risk, improve efficiency, and unlock the full value of their data.

Meet Us at the Conference

We look forward to connecting at the 12th Master Data and Data Governance Excellence in Life Sciences Conference and discussing how Life Sciences organizations can move from ambition to execution.

If you are navigating data complexity, regulatory pressure, or AI readiness, let’s connect. We’d love to discuss your challenges, and share our proven strategies and solutions to complex information management challenges.

Copenhagen is Around the Corner: Veeva R&D Summit Europe

Copenhagen is Around the Corner: Veeva R&D Summit Europe

Veeva R&D Summit Europe is only a few short months away, and fme’s experts are preparing to share how we help organizations harness the full power of Veeva to enable digital transformation and long-term growth. With its unified suite of applications, Veeva serves as a strategic hub for regulated content and data, designed to improve collaboration, strengthen compliance, and accelerate speed to market.

Realizing that value, however, depends on more than platform configuration alone.

Data as the Critical Enabler

Like any enterprise technology solution, the success of Veeva is directly tied to the quality, structure, and regulatory integrity of the data it manages. To unlock the full capability of the platform, data must be accurate, complete, governed, and migration-ready from day one.

For life sciences organizations, this is a complex and high-stakes undertaking. Fragmented repositories, inconsistent metadata, missing lineage, and stringent GxP validation requirements introduce risk that can delay transformation and increase compliance exposure.

To reduce risk and ensure long-term platform value, your migration approach must be:

  • Governed and accountable, with defined ownership, stewardship, and documented business rules
  • Profiled and transparently assessed, identifying completeness gaps and cross-object dependencies
  • Systematically remediated and standardized, aligned to controlled vocabularies and target-state metadata models
  • Validated within GxP- and CSV-aligned frameworks, with full traceability and audit-ready documentation

By addressing these elements proactively, organizations position Veeva to deliver sustained regulatory confidence and measurable operational value.

Trusted for the Industry’s Most Demanding Migrations

Delivering value on Veeva requires proven execution in complex, regulated environments.

fme supports large-scale Vault migrations involving millions, and in our most recent cases tens of millions, of documents and records, executed under compressed timelines and strict compliance requirements. Our methodology is tailored to each organization’s operating model, regulatory landscape, and technical architecture, whether deploying globally or through phased rollouts.

By combining structured Data Readiness with Veeva-certified accelerators like migration-center® and our AI-assisted MetadataAssist℠ engine, we ensure governed, validated, and migration-ready data, enabling a controlled, compliant transition to Vault.

With fme, you gain a strategic partner focused on long-term platform success, not just system go-live.

Ready to explore your path to Veeva?

Before you travel to the Veeva R&D Summit Europe in May, download our Veeva capabilities overview below to learn more about our services, tools, and client success stories. Then, we’ll schedule a discovery meeting where we’ll discuss your current environment (or environments) and walk through the next steps for accelerating your Veeva transformation.

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

An annual staple of the regulatory industry, DIA’s RSIDM brings together industry and regulatory stakeholders to discuss evolving data standards, requirements and effective data management strategies. This year, fme’s regulatory experts David Gwyn, Frank D’Entrone and Scott Coles will be attending and answering questions in Booth #116. Stop by and see us! We’d love to discuss your challenges and plans for 2026, and share our proven solutions for managing complex regulatory submissions.

The Real Story: Data Quality Transformation

As data migration experts for the Life Sciences industry, we’ve helped the world’s largest organizations move complex regulatory ecosystems into platforms and solutions that align with their business processes and goals. Through our experiences, we’ve also realized that the actual migration is only one chapter of a much larger story.

In fact, the most urgent and impactful challenges our clients face aren’t about switching platforms. They’re about the quality, readiness, governance, and trustworthiness of the data they already have. And according to our clients, that’s where fme shines far brighter than other providers and especially the newest ‘intelligent’ solutions.

We Are Data Quality Transformation Specialists

fme understands the organization and structure of a client’s data is a reflection of the meaning, use and purpose of the information embedded within. Data, metadata and content all add essential context to data, and each detail needs to be available to realize its full value.

This is why clients come to us; they recognize fme’s experts can evaluate and enrich their data before incorporating it into their technology platform and business processes. Whether it’s organizing legacy content, remediating years of inconsistent metadata, strengthening governance practices, or establishing stewardship models that scale across global regulatory teams, fme knows where to look, and how to ensure every element is structured for efficient and contextual use.

This is the work we’re doing right now—multi-million-dollar data readiness and remediation initiatives—with some of the world’s largest and most complex Life Sciences companies. These aren’t migration projects. They’re data projects that emphasize critical concepts:

  • Data readiness is the foundation for modernization and digital transformation.
  • Governance and stewardship drive regulatory confidence.
  • Quality transformation unlocks efficiency, compliance, and innovation.

And they reflect a reality that’s becoming impossible to ignore:
You don’t have to move to a new platform to improve. You just need better data.

Understand Where You Are First

This has been one of the biggest expansions in the strategies we use to serve our clients. A transformation doesn’t start with technology change. It starts with understanding your current state, and building the pathway to allow your data to power your business goals.

fme’s solutions like MetadataAssist℠ and HealthCheckAssist℠ are strategically designed to provide regulatory and RIM teams with a fast, structured way to evaluate:

  • What data exists
  • How clean or accurate it is
  • How well metadata models are applied
  • Where governance gaps are limiting efficiency
  • What improvements can be made without moving platforms

In many cases, clients discover that a migration is unnecessary, or at least not urgent. By improving their data quality and governance practices, they can dramatically increase the value of the systems they already use.

To Migrate or Not: Choosing What’s Next

Of course, some organizations ultimately decide that their current platform can’t support where they want their business to go. When that happens, we help them choose their next solution with clear quantitative and qualitative data to cut through the marketing jargon and seller-lingo that can obfuscate true capabilities and benefits.

SelectAssist℠ is a unique offering that pairs our regulatory experts with client stakeholders to guide them through detailed platform evaluations and selection based on:

  • Regulatory workflows
  • Data and metadata requirements
  • Change readiness
  • Long-term scalability
  • Integration and interoperability needs

It’s important to clarify that while fme has many platform partners, our goal is to guide clients to the best solution for their unique goals. We provide a holistic, data-justified perspective focused on their needs, not a quarterly sales quota.

When Migration Is the Answer, We Deliver with Precision

When the data is optimized, technology is selected, and the organization is ready to move platforms, fme’s 30 years of migration experience come into play. We have unmatched knowledge, proven methodologies and acceleration toolsets to execute seamless regulatory content and data migrations at scale most service providers have never touched.

We combine:

  • AI-driven automation
  • Proven methodologies
  • Industry-leading tools
  • Deep regulatory and compliance expertise

After hundreds of successful migration projects, we have the skill and knowledge to deliver a seamless, accurate, and validated transition first time, every time.

Learn More about Data Quality Transformation

fme is evolving along with our clients’ needs. The industry is hungry for organizations that understand not just platforms, but the data that fuels regulatory compliance, submission quality, operational efficiency, and innovation.

So when we say we’re data quality transformation specialists, we mean:

  • We assess.
  • We remediate.
  • We govern.
  • We steward.
  • We prepare for the future.
  • And yes, when it’s the right time, we migrate.

But the story always starts with data quality. Do you REALLY know yours?

If you want to understand the value your data could be delivering, or if you’re struggling to achieve efficiency and compliance with the information you already have, we’re here to help you make it happen. Download the resource below to learn more.

Deep Dive into Regulatory Solutions at DIA RSIDM 2025

Deep Dive into Regulatory Solutions at DIA RSIDM 2025

This February, DIA RSIDM 2025 returns to Bethesda, MD, reaffirming its reputation as the premier event for regulatory professionals to exchange the best solutions for managing complex regulatory submissions. At fme, we specialize in helping pharmaceutical and biotechnology companies navigate regulatory challenges with expertise in selecting, planning, and migrating to RIM solutions tailored to their unique data, documents, and workflows. Visit us at Booth #315 during the RSIDM forum—we’d love to discuss your challenges and plans for 2025!

Operational Efficiency is Critical

Every day, pharmaceutical companies strive to demonstrate the efficacy of new discoveries and deliver life-changing medications to patients in need. To accelerate time-to-market and ensure safety, timely and high-quality regulatory submissions to health authorities are critical for review and approval.

However, the process is fraught with challenges. The sheer volume and complexity of data, documents, and information exchanged among multiple stakeholders and systems create significant hurdles in maintaining accurate, up-to-date documentation. Errors, omissions, or inconsistencies can lead to costly delays and disrupt expected release timelines.

Seasoned regulatory professionals recognize the importance of operational efficiency in managing regulatory information effectively throughout the development cycle, ensuring smooth and successful submissions.

Keys to RSIDM Efficiency and Success

Efficiency and success in regulatory operations depend on seamlessly aligning people, processes, and technology throughout a medication’s journey—from conception to patient use. With years of experience and a proven track record, fme has gained deep insights into the complexities of every phase of this journey. This expertise has enabled us to develop and refine methodologies that:

  • Analyze existing systems and workflows
  • Align requirements with tailored technology solutions
  • Ensure data and documents are accurately classified for discovery and use

fme’s experts combine a deep understanding of the product development lifecycle with extensive experience in regulatory projects. Staying ahead of evolving data standards, requirements, and technology trends, we guide clients toward the best solutions for today while future-proofing their decisions to deliver long-term ROI.

Download this overview to see how fme can help you achieve regulatory excellence and why we are recognized as a leader in content management solutions for regulatory environments.

Connect with fme at DIA RSIDM 2025

Last year, fme’s David Gwyn spoke on “Leveraging Structured Content Authoring in Regulatory Submissions: Real-World Experience, Industry Insights and Tools.” This presentation focused on the latest EDM Structured Reference Model team developments, showcasing how their work influences industry-wide adoption. For more information, view the full details of the session here.

For 2025, David will be joined by RIM experts Jonathan Byars and Frank D’Entrone to provide their expertise on effective strategies to align people, processes, and technology for RIM success. fme’s experience across platforms, industries, and global territories gives us unparalleled insights into the best strategies and solutions and how to ensure a successful journey to regulatory excellence.

What are your challenges for 2025? Use the form below to request a no-cost discovery session and we’ll schedule a time to discuss your concerns and possible solutions. If you are attending RSIDM 2025, join us at Booth #315 and we can start the conversation in person! If you can’t attend this year, download the overview and let us know if you’d like to talk.

The DIA RSIDM 2025 Educational Tracks

The educational tracks for this year’s conference reflect the continued integrated communication challenges regulatory professionals face within a quickly evolving technology landscape. Download the overview above to learn more about how we can support your team in each.

  • Track 1: Building and Sustaining Successful RSIDM Foundations
    • This track is designed for attendees who are either new to the field or seek a comprehensive review of the evolving dynamics and intricacies that shape their day-to-day work.
  • Track 2: Optimizing Processes and Procedures
    • This track is tailored for intermediate-level professionals and focuses on what is needed to improve processes, procedures, and data to foster a culture of innovative practices and forward-thinking. Learn proven industry best practices and discuss the impact of new global regulations on your organization’s processes and procedures.
  • Track 3: Adopting Innovative Technologies
    • This intermediate to advanced track provides first-hand knowledge from global regulatory health authorities on the implementation of new technologies, policies, and guidelines. It also includes perspectives on how to incorporate technology advancements like artificial intelligence and automation, and how to assess their effectiveness and impact.
  • Track 4: Achieving Regulatory Excellence
    • This advanced track is designed for leadership roles, and includes examples and use cases from organizations that have achieved regulatory excellence. It covers a wide range of practical implementation strategies to support vision, cultural change, and commitment to innovation.

We are excited to participate in these valuable conversations with regulatory thought leaders and re-connect with industry colleagues! Find the full RSIDM 2025 agenda here, and contact us if you have any questions about the specific tracks or sessions offered. We look forward to seeing you there!

Join fme in Boston at the Veeva Summit: R&D and Quality

Join fme in Boston at the Veeva Summit: R&D and Quality

The 2024 Veeva Summit: R&D and Quality is in Boston in a few weeks and fme is honored to be one of the few certified partners to have been selected as a Gold sponsor. We look forward to sharing our experience and strategies with the Veeva community again this year. We cordially invite you to join us to network, share strategies and learn more about the capabilities of the Veeva platform.

Veeva Summit

With over 2,000 life science industry professionals attending, the Veeva Summit in Boston is the best place to get first-hand details on today’s most effective R&D and Quality strategies and solutions for content management. fme is a certified partner supporting the Veeva platform for Life Sciences firms through selection, migration and maintenance, so we’ll be sharing our proven methodologies to best configure, utilize, and support this powerful platform and leverage its capabilities to achieve business goals.

Each year, the Veeva Summit deliver unique value to attendees:

  • Gain insights into the latest features and enhancements within Veeva’s powerful platform, and how it can help you achieve your business goals.
  • Understand how fme can help plan and optimize your Veeva environment, ensuring seamless integration, operation, and maximum ROI.
  • Exchange ideas, network, and learn from industry professionals to help you stay ahead of industry trends and competition.

Why Migrate to Veeva Vault?

Throughout the Veeva Summit, clients and partners will be sharing their knowledge and strategies for planning, integrating, utilizing and maintaining the platform. Veeva Vault offers a unified suite of applications designed to manage the critical content and data in life sciences. By centralizing information across quality, regulatory, and clinical operations, Veeva Vault enhances collaboration, improves compliance, and accelerates time to market. However, the migration to such a robust system is not without its challenges. Moving large volumes of data from legacy systems, databases, and various content repositories requires expertise, precision, and a deep understanding of the unique needs of the life sciences industry.

fme at Veeva Summit

With decades of experience in the life sciences sector, fme has established itself as a leader in data and document migration services and is your trusted partner for Veeva Vault migrations. Drawing on my personal experience in migrating legacy data and documents, I understand firsthand the challenges clients face—from navigating complex regulatory requirements to ensuring data accuracy and integrity throughout the migration process. This insight drives our commitment to making your migration to Veeva Vault as seamless as possible.

Industry Expertise That Sets Us Apart

At fme, we bring extensive experience in the life sciences industry to every migration project. Having personally worked on numerous migrations, I know fme’s expert team understands the intricate challenges that come with moving critical data and documents. Our team have extensive knowledge of the stringent regulatory requirements that govern the industry, including GxP compliance, and we ensure that every step of the migration process meets these standards. Our expertise spans quality management, regulatory affairs, and clinical operations, making us uniquely qualified to handle the nuanced needs of your migration to Veeva Vault.

Comprehensive Migration Services

Our migration services are comprehensive, covering every phase of the migration journey. We start by thoroughly assessing your existing systems and data to understand the migration scope and identify potential challenges. Leveraging our many years of migration experience, we collaborate with you to create a migration plan that aligns with your business objectives and addresses concerns upfront. We then meticulously map your data to the Veeva Vault structure, ensuring all necessary transformations are applied for accuracy and readiness. Utilizing our specialized tool, migration-center, we handle the extraction, transformation, and loading of data from various source systems into Veeva Vault, with rigorous validation processes to meet all regulatory requirements. Post-migration, we provide ongoing support to ensure your Veeva Vault environment functions smoothly, offering training, troubleshooting, and customization as needed, backed by my experience in anticipating and resolving issues.

migration-center: The Power Behind Our Migrations.

migration-center, our purpose-built migration tool, is designed to simplify even the most complex migrations. Capable of supporting over 250 source-to-target system combinations, migration-center seamlessly handles content extraction and migration to Veeva Vault from databases, file shares, cloud platforms, and legacy applications. This flexibility ensures that no matter where your data currently resides, we can migrate it efficiently and accurately to Veeva Vault.

Tailored Solutions for Unique Needs

We understand that every organization is different, with unique challenges and requirements. That’s why we don’t take a one-size-fits-all approach. Having personally navigated various migration scenarios, I know how important it is to tailor our services to meet your specific needs. Whether you’re migrating a small dataset or a complex array of content types, we have the expertise and tools to deliver a solution that works for you.

A Commitment to Compliance and Quality

In the life sciences industry, compliance isn’t optional—it’s essential. We are experts in ensuring that your migration process adheres to the strictest regulatory standards. From GxP compliance to meticulous documentation, we leave nothing to chance. Our team works closely with your quality assurance teams to validate every aspect of the migration, giving you peace of mind that your data is accurate, complete, and ready for regulatory scrutiny.

Why Choose fme for Your Veeva Vault Migration?

Migrating to Veeva Vault is a significant undertaking, but with fme as your partner, it doesn’t have to be daunting. We combine deep industry knowledge, cutting-edge tools, and a client-centric approach to deliver migration services that are seamless, secure, and compliant. My personal experience in the life sciences industry has equipped me with the insights necessary to anticipate challenges and guide you through a successful migration.

Contact Us Today!

Ready to make the move to Veeva Vault? Contact us today to learn how fme can support your migration and help you unlock the full potential of your content management system. We’ll schedule a discovery meeting with our Veeva experts to discuss your current challenges and introduce the range of possibilities and next steps to accelerate your journey to success.

Not Attending Veeva Summit?

Not attending the Veeva Summit in Boston this year? That’s an even better reason to contact us to schedule a personalized presentation. We’ll share the newest updates and announcements from Veeva, and discuss solutions for your short- and long-term challenges.